Elizabeth C Neil

Elizabeth C Neil is an Associate Professor in the Department of Neurology at the University of Minnesota, School of Medicine, specializing in neuro-oncology and the cellular mechanisms of cancer. Her research is centered on improving outcomes for patients with glioblastoma through innovative clinical trials and translational research.

• Academic Rank: Associate Professor
• Institution: University of Minnesota
• School: School of Medicine
• Department: Department of Neurology
• Email: neile@umn.edu

Her research interests span neuro-oncology, glioblastoma therapeutics, hypofractionated radiotherapy, GammaTile brachytherapy, personalized cancer vaccines, and caregiver cognitive impacts. She investigates both tumor biology and patient-centered outcomes, contributing significantly to clinical advancements in brain tumor treatment.

The trends in her recent publications emphasize clinical innovation in glioblastoma management, including real-world data on personalized vaccines, immune monitoring during radiotherapy, and quality-of-life assessments for caregivers. Her work bridges laboratory insights with patient care, focusing on both efficacy and tolerability of novel therapies.

While no specific scientific awards are listed, her leadership as Principal Investigator on multiple high-profile, multi-center Phase 3 clinical trials with industry partners such as Novocure, CNS Pharmaceuticals, and the Ivy Brain Tumor Center underscores her national recognition and research impact.

Dr. Neil leads an active research program with significant grant funding, directing 11 major projects, including active Phase 3 trials in newly diagnosed and recurrent glioblastoma. Her work involves extensive collaboration across institutions and disciplines, though specific labs or teams are not detailed in the text.